514 related articles for article (PubMed ID: 16260731)
1. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.
Netea MG; Azam T; Ferwerda G; Girardin SE; Walsh M; Park JS; Abraham E; Kim JM; Yoon DY; Dinarello CA; Kim SH
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16309-14. PubMed ID: 16260731
[TBL] [Abstract][Full Text] [Related]
2. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
[TBL] [Abstract][Full Text] [Related]
3. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.
Hedl M; Abraham C
J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536
[TBL] [Abstract][Full Text] [Related]
5. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
[TBL] [Abstract][Full Text] [Related]
6. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
[TBL] [Abstract][Full Text] [Related]
7. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
[TBL] [Abstract][Full Text] [Related]
8. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
[TBL] [Abstract][Full Text] [Related]
9. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
Fritz JH; Girardin SE; Fitting C; Werts C; Mengin-Lecreulx D; Caroff M; Cavaillon JM; Philpott DJ; Adib-Conquy M
Eur J Immunol; 2005 Aug; 35(8):2459-70. PubMed ID: 16021602
[TBL] [Abstract][Full Text] [Related]
10. The role of nucleotide-binding oligomerization domain 1 during cytokine production by macrophages in response to Mycobacterium tuberculosis infection.
Lee JY; Hwang EH; Kim DJ; Oh SM; Lee KB; Shin SJ; Park JH
Immunobiology; 2016 Jan; 221(1):70-5. PubMed ID: 26255090
[TBL] [Abstract][Full Text] [Related]
11. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
Tada H; Aiba S; Shibata K; Ohteki T; Takada H
Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
[TBL] [Abstract][Full Text] [Related]
13. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype.
Netea MG; Ferwerda G; de Jong DJ; Girardin SE; Kullberg BJ; van der Meer JW
Neth J Med; 2005 Sep; 63(8):305-8. PubMed ID: 16186640
[TBL] [Abstract][Full Text] [Related]
14. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
15. Synergistic enhancement of Toll-like receptor responses by NOD1 activation.
van Heel DA; Ghosh S; Butler M; Hunt K; Foxwell BM; Mengin-Lecreulx D; Playford RJ
Eur J Immunol; 2005 Aug; 35(8):2471-6. PubMed ID: 16021603
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
[TBL] [Abstract][Full Text] [Related]
17. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
[TBL] [Abstract][Full Text] [Related]
18. NOD1 and NOD2 stimulation triggers innate immune responses of human periodontal ligament cells.
Jeon DI; Park SR; Ahn MY; Ahn SG; Park JH; Yoon JH
Int J Mol Med; 2012 Apr; 29(4):699-703. PubMed ID: 22218461
[TBL] [Abstract][Full Text] [Related]
19. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation.
Kramer M; Netea MG; de Jong DJ; Kullberg BJ; Adema GJ
J Leukoc Biol; 2006 Apr; 79(4):860-6. PubMed ID: 16461743
[TBL] [Abstract][Full Text] [Related]
20. MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3.
Pan Q; Mathison J; Fearns C; Kravchenko VV; Da Silva Correia J; Hoffman HM; Kobayashi KS; Bertin J; Grant EP; Coyle AJ; Sutterwala FS; Ogura Y; Flavell RA; Ulevitch RJ
J Leukoc Biol; 2007 Jul; 82(1):177-83. PubMed ID: 17403772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
